5.57
price up icon3.92%   0.21
after-market Dopo l'orario di chiusura: 5.84 0.27 +4.85%
loading
Precedente Chiudi:
$5.36
Aprire:
$4.93
Volume 24 ore:
191.43K
Relative Volume:
0.79
Capitalizzazione di mercato:
$273.73M
Reddito:
-
Utile/perdita netta:
$-76.41M
Rapporto P/E:
-2.901
EPS:
-1.92
Flusso di cassa netto:
$-64.56M
1 W Prestazione:
+2.20%
1M Prestazione:
-25.73%
6M Prestazione:
-52.19%
1 anno Prestazione:
-22.53%
Intervallo 1D:
Value
$4.93
$5.65
Intervallo di 1 settimana:
Value
$4.93
$5.67
Portata 52W:
Value
$4.84
$12.38

Aura Biosciences Inc Stock (AURA) Company Profile

Name
Nome
Aura Biosciences Inc
Name
Telefono
(617)500-8864
Name
Indirizzo
80 GUEST STREET, BOSTON
Name
Dipendente
106
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-24
Name
Ultimi documenti SEC
Name
AURA's Discussions on Twitter

Confronta AURA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
AURA
Aura Biosciences Inc
5.57 273.73M 0 -76.41M -64.56M -1.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-07-25 Iniziato H.C. Wainwright Buy
2023-07-27 Iniziato Scotiabank Sector Outperform
2023-04-17 Ripresa BTIG Research Buy
2022-07-19 Iniziato JMP Securities Mkt Outperform

Aura Biosciences Inc Borsa (AURA) Ultime notizie

pulisher
Apr 18, 2025

Oncology’s Most Eligible Unpartnered Assets - insights.citeline.com

Apr 18, 2025
pulisher
Apr 18, 2025

Vanguard Group Inc. Acquires 112,296 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

Aura Biosciences SVP Amy Elazzouzi sells $4,924 in stock By Investing.com - Investing.com Canada

Apr 17, 2025
pulisher
Apr 16, 2025

Aura Biosciences executive sells $39,319 in stock By Investing.com - Investing.com Canada

Apr 16, 2025
pulisher
Apr 16, 2025

Aura Biosciences executive sells $39,319 in stock - Investing.com

Apr 16, 2025
pulisher
Apr 16, 2025

Aura Biosciences SVP sells $4,924 in stock - Investing.com

Apr 16, 2025
pulisher
Apr 16, 2025

Aura Biosciences SVP Amy Elazzouzi sells $4,924 in stock - Investing.com

Apr 16, 2025
pulisher
Apr 14, 2025

Wellington Management Group LLP Has $1.08 Million Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

American Century Companies Inc. Has $392,000 Stake in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Q1 EPS Estimate for Aura Biosciences Decreased by Analyst - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

Aura Biosciences, Inc. (NASDAQ:AURA) Receives Consensus Rating of “Buy” from Analysts - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Aura Biosciences stock hits 52-week low at $5.05 - Investing.com Australia

Apr 10, 2025
pulisher
Apr 09, 2025

Aura Biosciences stock hits 52-week low at $5.05 By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 06, 2025

Is Aura Biosciences (AURA) The Small Cap Stock with Huge Upside Potential? - Insider Monkey

Apr 06, 2025
pulisher
Apr 02, 2025

Aura Biosciences expands board with oncology leader By Investing.com - Investing.com South Africa

Apr 02, 2025
pulisher
Apr 02, 2025

Aura Biosciences Appoints Teresa Bitetti To Board - citybiz

Apr 02, 2025
pulisher
Apr 02, 2025

Aura Biosciences Announces Appointment Of Teresa Bitetti To Board Of Directors - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

Aura Biosciences Expands Board with New Director Appointment - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Aura Biosciences expands board with oncology leader - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors - GlobeNewswire

Apr 02, 2025
pulisher
Mar 31, 2025

Aura Biosciences stock hits 52-week low at $5.75 amid market challenges By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Aura Biosciences stock hits 52-week low at $5.75 amid market challenges - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

Are Investors Keen On Selling Holdings In Aura Biosciences Inc (NASDAQ: AURA)? - stocksregister.com

Mar 31, 2025
pulisher
Mar 29, 2025

(AURA) Long Term Investment Analysis - news.stocktradersdaily.com

Mar 29, 2025
pulisher
Mar 28, 2025

Q1 Earnings Estimate for AURA Issued By HC Wainwright - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Aura Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025
pulisher
Mar 27, 2025

Institutional investors may adopt severe steps after Aura Biosciences, Inc.'s (NASDAQ:AURA) latest 20% drop adds to a year losses - Simply Wall St

Mar 27, 2025
pulisher
Mar 27, 2025

Aura Biosciences Inc: Promising Clinical Progress and Financial Stability Justify Buy Rating - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

What is HC Wainwright’s Forecast for AURA Q3 Earnings? - Defense World

Mar 27, 2025
pulisher
Mar 27, 2025

Aura Biosciences Stock (AURA) Continues to Slide Despite Promising Clinical Progress - markets.businessinsider.com

Mar 27, 2025
pulisher
Mar 26, 2025

Aura Biosciences price target lowered to $19 from $21 at Citizens JMP - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

Character Biosciences gains $93m for precision eye disease therapies - Pharmaceutical Technology

Mar 26, 2025
pulisher
Mar 26, 2025

Bel-sar shows promising safety, efficacy in NMIBC - Urology Times

Mar 26, 2025
pulisher
Mar 26, 2025

Aura Biosciences stock target cut to $19 by JMP Securities - Investing.com UK

Mar 26, 2025
pulisher
Mar 26, 2025

Aura Biosciences Reports Progress in Cancer Trials - TipRanks

Mar 26, 2025
pulisher
Mar 25, 2025

Aura Biosciences Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView

Mar 25, 2025
pulisher
Mar 25, 2025

Aura Biosciences stock target raised to $25 by H.C. Wainwright - Investing.com UK

Mar 25, 2025
pulisher
Mar 25, 2025

Promising Clinical Data and Abscopal Effect Drive Buy Rating for Aura Biosciences Inc. - TipRanks

Mar 25, 2025
pulisher
Mar 24, 2025

Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

Aura Biosciences Reports Positive Phase 1 Trial Results in Non-Muscle Invasive Bladder Cancer and Advances Clinical Pipeline - Nasdaq

Mar 24, 2025
pulisher
Mar 24, 2025

Aura's Cancer Drug Delivers Complete Responses as $151M Cash Runway Extends to 2026 - Stock Titan

Mar 24, 2025
pulisher
Mar 24, 2025

Promising Phase 1 Results for Aura Biosciences’ Bel-sar in Bladder Cancer Boost Buy Rating - TipRanks

Mar 24, 2025
pulisher
Mar 24, 2025

Aura reports promising bladder cancer trial results By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Aura Biosciences stock hits 52-week low at $6.58 amid market shifts - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

Buy Recommendation for Aura Biosciences: Promising Phase 1 Trial Results and Dual Mechanism of Action in Bladder Cancer Treatment - TipRanks

Mar 24, 2025
pulisher
Mar 24, 2025

Aura Biosciences stock hits 52-week low at $6.58 amid market shifts By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Buy Rating for Aura Biosciences Inc. Driven by Promising Phase 1 Trial Results and Future Revenue Potential - TipRanks

Mar 24, 2025

Aura Biosciences Inc Azioni (AURA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
Capitalizzazione:     |  Volume (24 ore):